Revenue Recognition and Collaborative Arrangements (Tables)

6 Months Ended

Jun. 30, 2018

Revenue Recognition and Collaborative Arrangements

Schedule of revenue from collaborative arrangements

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2018		2017		2018		2017
Royalties from a related party - RELVAR/BREO	$	57,515	$	54,645	$	103,675	$	93,334
Royalties from a related party - ANORO		10,656		7,152		19,380		12,190
Royalties from a related party - TRELEGY		2,371		—		3,323		—
Total royalties from a related party		70,542		61,797		126,378		105,524
Less: amortization of capitalized fees paid to a related party		(3,456)		(3,456)		(6,912)		(6,912)
Royalty revenue		67,086		58,341		119,466		98,612
Strategic alliance - MABA program license		—		221		—		442
Total net revenue from GSK	$	67,086	$	58,562	$	119,466	$	99,054